GleanMark

GO-2 Trademark

GO-2 is a USPTO trademark filed by GTX MEDICAL B.V.. Status: Cancelled.

Trademark Facts

MarkGO-2
Serial Number87429765
Registration Number5791247
StatusCancelled
Filing Date2017-04-28
Registration Date2019-07-02
Mark TypeWord
Nice Classes009 (Electronics & Software), 010 (Medical Devices)
OwnerGTX MEDICAL B.V.
Attorney of RecordB. Anna McCoy
Prosecution Events45
Latest EventC8.. on 2026-01-16

Goods & Services

Information technology and audiovisual equipment in the field of neuromodulation devices, namely, digital video recorders, audio visual receivers, transmitters, speakers, displays and control devices therefore, video projectors and remote controls, televisions, amplifiers, loud speakers and components therefor; magnets, magnetizers and demagnetizers; cables for electricity for use in treatment of patients for physical therapy purposes; scientific research and laboratory apparatus, educational apparatus and simulators, namely, neuromodulation and neurostimulation planning and simulation tools and neuromodulation and neurostimulation planning systems for use in treatment of patients for physical therapy purposes | Medical and veterinary apparatus and instruments, namely, neuromodulation apparatuses and neurostimulation apparatuses; diagnostic examination, and monitoring equipment, namely, neural monitoring equipement and EMG apparatuses; prosthetic and artificial implants, namely, artificial spinal implants and prosthetic neural implants; electric nerve stimulators for spinal cord injuries for physical therapy purposes; nerve muscle stimulators for spinal cord injuries for physical therapy purposes; transcutaneous electrical muscle stimulators for spinal cord injuries for physical therapy purposes; electronic stimulators for medical use for spinal cord injuries for physical therapy purposes; electronic nerve stimulators for medical use for spinal cord injuries for physical therapy purposes; leads for use with implantable stimulators; medical apparatus and instruments for the treatments of patients with neuromotor impairment and/or paraplegia and/or locomotion disabilities or handicaps; devices for treatment using electricity for use in treatment of patients for physical therapy purposes; optical devices, enhancers and correctors, namely, augmented reality glasses and displays for use in treatment of patients for physical therapy purposes; safety, security, protection and signalling devices, namely, markers and protectors for use in treatment of patients for physical therapy purposes; measuring, detecting and monitoring instruments, indicators and controllers, namely, neuromodulation controllers and neurostimulation controllers for use in treatment of patients for physical therapy purposes

Related